Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Tuberculosis Delays Childhood Cancer Diagnosis and Disrupts Treatment Across Asia: A Cross-Sectional Survey

Tuberculosis Delays Childhood Cancer Diagnosis and Disrupts Treatment Across Asia: A Cross-Sectional Survey

November 21, 2026 Health Desk Health

Tuberculosis (TB) and childhood cancer frequently overlap in Asian clinical practice, resulting in diagnostic delays and disrupted oncologic care, according to a cross-sectional study published in Cureus.

Physicians across 25 countries reported that the clinical similarity between these conditions often forces empirical antitubercular therapy, which can mask underlying malignancies.

Key Clinical Takeaways:

  • Hodgkin lymphoma is the most common malignancy misdiagnosed as TB, according to 90.2% of surveyed clinicians.
  • Many physicians report that drug-drug interactions between antitubercular treatments and chemotherapy necessitate interruptions to cancer care.
  • Standardized screening protocols for TB remain absent in most pediatric oncology centers across the region, excluding selective testing before stem cell transplantation.

Diagnostic Challenges and Misdiagnosis Risks

The study, which analyzed responses from 41 pediatric oncology physicians between July and September 2023, highlights how non-specific symptoms—such as fever, weight loss, and lymphadenopathy—complicate the identification of cancer. Because TB remains highly prevalent in many parts of Asia, clinicians often initiate empirical treatment when microbiologic confirmation is difficult to obtain. This practice frequently delays the start of definitive cancer therapy.

The survey identified specific malignancies most prone to diagnostic confusion. Hodgkin lymphoma was the leading diagnostic pitfall, cited by 37 of the 41 respondents (90.2%). Non-Hodgkin lymphoma and leukemia were also frequently cited as being initially misidentified as TB. These delays are particularly concerning given that childhood cancer survival rates in low- and middle-income countries already lag behind those in high-income settings.

Treatment Interruptions and Clinical Management

Managing both conditions at the same time creates a heavy treatment burden. The pharmacological profile of antitubercular therapy often conflicts with standard chemotherapy regimens, leading to complex drug-drug interactions. Among the physicians surveyed, 65.8% (n = 27) reported that these interactions forced them to interrupt cancer treatments. In addition, 44% (n = 18) of respondents indicated they had to modify the intensity of oncologic therapy to accommodate antitubercular regimens.

Clinical Challenge Physician Reporting Frequency
Hodgkin lymphoma misdiagnosed as TB 90.2%
Non-Hodgkin lymphoma misdiagnosed as TB 46.3%
Cancer treatment interruptions due to drug interactions 65.8%
Modifications to cancer therapy intensity 44%

Regional Variations in Clinical Practice

The survey included pediatric oncology centers across 25 countries, covering a broad spectrum of World Bank economic classifications. While all participating centers managed both hematologic malignancies and solid tumors, the inconsistency in diagnostic resources—ranging from tuberculin skin testing to interferon-gamma release assays—contributes to the heterogeneity of care.

Despite these differences, the study highlights a universal need for stronger, integrated diagnostic algorithms that can distinguish between TB and malignancy earlier in the clinical pathway.

For clinicians managing these complex cases, the findings suggest that current reliance on empirical treatment may be unsustainable. Pediatric hematologists and oncologists are increasingly encouraged to seek early consultation with infectious disease specialists or radiologists to refine diagnostic criteria.

Establishing a multidisciplinary team approach at tertiary referral centers may mitigate the risks associated with delayed cancer diagnosis and help balance the aggressive requirements of chemotherapy with the management of chronic infections.

Future prospective research is necessary to move beyond survey-based perceptions and establish evidence-based guidelines for integrated care. As diagnostic tools evolve, the focus must shift toward standardized screening protocols that protect vulnerable pediatric populations from both disease-related immune dysfunction and the complications of overlapping therapies.

Cureus, which was originally established as PeerEMed in 2009 before adopting its current name in 2012, operates as a web-based, open-access medical journal. Unlike traditional publications, it emphasizes an unusually fast pre-publication peer-review process, supplemented by a unique post-publication evaluation system known as the Scholarly Impact Quotient.

The journal became part of the Springer Nature group in 2022. While it maintains a broad indexing presence in databases like PubMed Central and Google Scholar, it has faced scrutiny regarding its editorial oversight and the integrity of its peer-review practices, leading to several high-profile retractions and its removal from the Web of Science index in 2025.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • SmartWorld: iPhone 16 Gets a18 Chip, Smaller 6.1-Inch Display vs 15 Plus
  • Autonomous Medical AI MIRA Achieves 88.9% Diagnostic Accuracy and Outperforms Specialists in Guideline Compliance
  • Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
  • Median Net Worth Peaks at 75+ in the Fed's Survey, but the Lead Is Thin (daybreakwire.com)

Related

Asia, childhood cancer, Tuberculosis

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service